ANNOUNCEMENT

MedCity CONVERGE gathers payers, providers, medtech, pharma, digital health, investors, policymakers and more.

Staff

Follow Staff: Website |


Supreme Court: FTC can challenge deals that keep cheaper generic drugs off market

Supreme Court: FTC can challenge deals that keep cheaper generic drugs off market

June 17, 2013 11:26 am by | 0 Comments

WASHINGTON (Reuters) - The U.S. Supreme Court ruled on Monday that the Federal Trade Commission can challenge deals that brand-name drug companies make with generic rivals to keep cheaper products ... Read more

Four more deaths from MERS coronavirus in Saudi Arabia

Four more deaths from MERS coronavirus in Saudi Arabia

June 17, 2013 9:23 am by | 0 Comments

DUBAI (Reuters) - Four more people have died and three more have fallen ill in Saudi Arabia from the new SARS-like coronavirus MERS-CoV, the Saudi Health Ministry said on Monday.The ... Read more


Roche’s Avastin approved in Japan for treatment of aggressive brain cancer

Roche’s Avastin approved in Japan for treatment of aggressive brain cancer

June 17, 2013 1:39 am by | 0 Comments

ZURICH (Reuters) - Japan's health ministry has approved drug Avastin for the treatment of aggressive brain cancer in Japan, Swiss pharmaceuticals company Roche said on Monday.Avastin is the first new ... Read more

New biotech company may prevent blood clots through its anticoagulant drug

New biotech company may prevent blood clots through its anticoagulant drug

June 16, 2013 7:04 pm by | 0 Comments

LONDON (Reuters) - British scientists have won early financial backing for a new kind of anticoagulant drug they believe may prevent dangerous blood clots without causing bleeding - a previously ... Read more

The entire healthcare economy depends on young people doing what Obamacare asks

The entire healthcare economy depends on young people doing what Obamacare asks

June 15, 2013 11:15 am by | 0 Comments

WASHINGTON, June 14 (Reuters) - In the final months leading up to the launch of the key piece of President Barack Obama's healthcare reforms, the administration is preparing a public-education ... Read more

Saudi Health Ministry reports another death from MERS, brings global total to 33

Saudi Health Ministry reports another death from MERS, brings global total to 33

June 14, 2013 2:14 pm by | 0 Comments

RIYADH (Reuters) - One more person has died and two more have fallen ill in Saudi Arabia from the new SARS-like coronavirus, MERS-CoV, the Saudi Health Ministry said on Friday.Saudi ... Read more

India’s Ranbaxy has “ambitious growth plan” in U.S., will file generic drugs for marketing exclusivity

India’s Ranbaxy has “ambitious growth plan” in U.S., will file generic drugs for marketing exclusivity

June 14, 2013 12:05 pm by | 0 Comments

MUMBAI (Reuters) - Ranbaxy Laboratories, India's No.1 drugmaker by sales, plans to file three to four generic drug applications every year that can earn it a six-month marketing exclusivity in ... Read more


Teva under investigation in Paris, six deaths may have resulted from packaging mistakes

Teva under investigation in Paris, six deaths may have resulted from packaging mistakes

June 14, 2013 12:00 pm by | 0 Comments

"Bloomberg" reports that Paris prosecutors have opened an investigation into drug packaging mistakes at a Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) plant in Sens, in north-central France, which ... Read more

More research needed for use of anti-seizure drugs to treat women’s genital pain

More research needed for use of anti-seizure drugs to treat women’s genital pain

June 14, 2013 11:20 am by | 0 Comments

Based on these studies, "it's very difficult to make definitive statements on efficacy," said Dr. Raphael Leo, the study's author from the State University of New York at Buffalo. "Certainly, ... Read more

EU: Doctors should consider heart attack risks when prescribing painkiller

EU: Doctors should consider heart attack risks when prescribing painkiller

June 14, 2013 7:56 am by | 0 Comments

LONDON (Reuters) - Europe's drugs agency warned on Friday that use of the common painkiller diclofenac, especially in high doses, carries extra heart attack risks which should be taken into ... Read more

AstraZeneca embraces outsourcing by inviting outside experts to work at screening lab

AstraZeneca embraces outsourcing by inviting outside experts to work at screening lab

June 13, 2013 7:06 pm by | 0 Comments

LONDON (Reuters) - British drugmaker AstraZeneca is deepening its collaboration with academia by roping in more outside researchers to help to find new cancer drugs.Scientists at the Cancer Research UK ... Read more

Lilly stops trial of BACE inhibitors for Alzheimer’s due to liver problems

Lilly stops trial of BACE inhibitors for Alzheimer’s due to liver problems

June 13, 2013 5:08 pm by | 0 Comments

(Reuters) - Eli Lilly and Co said on Thursday it was halting a midstage clinical trial of an experimental Alzheimer's disease treatment due to potential liver toxicity problems.It was the ... Read more

Supreme Court: synthetic genetic material can be patented, but isolated DNA cannot

Supreme Court: synthetic genetic material can be patented, but isolated DNA cannot

June 13, 2013 10:25 am by | 0 Comments

WASHINGTON, June 13 (Reuters) - The U.S. Supreme Court on Thursday issued a mixed ruling in a case concerning patents held by Myriad Genetics Inc over the closely watched issue ... Read more

Lilly’s experimental rheumatoid arthritis drug effective in mid-stage study

Lilly’s experimental rheumatoid arthritis drug effective in mid-stage study

June 13, 2013 7:43 am by | 0 Comments

(Reuters) - Eli Lilly and Co and Incyte Corp said their experimental drug was effective in reducing painful symptoms associated with rheumatoid arthritis after 52 weeks of treatment.The drug, baricitinib, ... Read more

No, that’s not our final offer. GSK adds discount for Revolade, gets initial approval in UK

No, that’s not our final offer. GSK adds discount for Revolade, gets initial approval in UK

June 12, 2013 7:06 pm by | 0 Comments

LONDON (Reuters) - GlaxoSmithKline has finally won a green light from Britain's healthcare cost agency NICE for its platelet-boosting drug Revolade, after offering a price discount to the country's state-run ... Read more